Manufacturing
Stella-Jones Reports 2022 Year-End Results Anchored in Strong Business Fundamentals
Net income reached $241 million, or $3.93 per share
Mar 8, 2023
CENTOGENE to Participate in Upcoming Conferences in March
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, March 08, 2023 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today announced its conference schedule for March 2023. CENTOGENE representatives
Mar 8, 2023
Latest News
Show more
Sponsored
